Proteomic characterization of the effects of clofibrate on protein expression in rat liverLEONARD, Jean-Francois; COURCOL, Martine; GAUTIER, Jean-Charles et al.Proteomics (Weinheim. Print). 2006, Vol 6, Num 6, pp 1915-1933, issn 1615-9853, 19 p.Article

Effect of Clofibrate in Non-hemolytic Indirect Hyperbilirubinemia in Full Term NeonatesEGHBALIAN, Fatemeh; POURHOSSEIN, Abolfazl; ZANDEVAKILI, Hassan et al.Indian journal of pediatrics. 2007, Vol 74, Num 11, pp 1003-1006, issn 0019-5456, 4 p.Article

Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticalsKOMSTA, Lukasz; MISZTAL, Genowefa; MAJCHRZAK, Ewa et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 2, pp 408-414, issn 0731-7085, 7 p.Article

THE EFFECT OF CLOFIBRATE AND ANALOGS ON HUMAN POST-HEPARIN PLASMA LIPASES.GANESAN D; WHAYNE TF JR; WITIAK DT et al.1976; ARTERY; U.S.A.; DA. 1976; VOL. 2; NO 5; PP. 467-479; BIBL. 21 REF.Article

A COMPARATIVE STUDY OF THE INHIBITORY ACTIVITY OF CLOFIBRATE AND RELATED ANALOGS ON LIPOPROTEIN LIPASE IN VITRO = ETUDE COMPARATIVE DE L'ACTIVITE INHIBITRICE DU CLOFIBRATE ET DES ANALOGUES APPARENTES SUR LA LIPOPROTEINE LIPASE IN VITRO1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 3; PP. 228-231; BIBL. 45REF.Serial Issue

Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23YUZHONG MA; SACHDEVA, Karuna; JIRONG LIU et al.Biochemical pharmacology. 2005, Vol 69, Num 9, pp 1363-1371, issn 0006-2952, 9 p.Article

A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in ratsISHIHARA, Kenji; KATSUTANI, Naruo; AOKI, Toyohiko et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 3, pp 251-260, issn 1742-7835, 10 p.Article

Immunocytochemical study of cytochrome P450 4A induction in mouse eyeZHAO, C; SCHWARTZMAN, M. L; SHICHI, H et al.Experimental eye research. 1996, Vol 63, Num 6, pp 747-751, issn 0014-4835Article

IMPIEGO CLINICO DI CLOFIBRATO DI LISINA IN CONFRONTO A CLOFIBRATO IN PAZIENTI IPERDISLIPIDEMICI = DONNEES CLINIQUES SUR LE CLOFIBRATE DE LYSINE COMPARE AU CLOFIBRATE CHEZ DES MALADES HYPERDYSLIPIDEMIQUESMAGGI GC; ITALIANO D.1978; GAZZ. MED. ITAL.; ITA; DA. 1978; VOL. 137; NO 9; PP. 399-408; ABS. ENG; BIBL. 27 REF.Article

CLOFIBRATE AND RELATED ANALOGS.WITIAK DT; NEWMAN HAI; FELLER DR et al.1977; MEDICIN. RES. SER.; U.S.A.; DA. 1977; VOL. 7; PP. (296P.); BIBL. 91 P. 1/2; ISBN 0824766814Serial Issue

INDUCTION OF HEPATIC LONG-CHAIN ACYL-COA HYDROLASE BY CLOFIBRIC ACID ADMINISTRATIONKAWASHIMA Y; KATOH H; NAKAJIMA S et al.1983; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1983; VOL. 752; NO 1; PP. 182-185; BIBL. 27 REF.Article

Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafishRALDUA, Demetrio; ANDRE, Michèle; BABIN, Patrick J et al.Toxicology and applied pharmacology. 2008, Vol 228, Num 3, pp 301-314, issn 0041-008X, 14 p.Article

Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating speciesRINGSEIS, Robert; LUCI, Sebastian; SPIELMANN, Julia et al.European journal of pharmacology. 2008, Vol 583, Num 1, pp 11-17, issn 0014-2999, 7 p.Article

PPARα agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and up-regulate progesterone secretions in immortalized human trophoblast cellsHASHIMOTO, Fumie; OGUCHI, Yoshinobu; MORITA, Mieko et al.Biochemical pharmacology. 2004, Vol 68, Num 2, pp 313-321, issn 0006-2952, 9 p.Article

DIE LANGZEITBEHANDLUNG DER VERSCHIEDENEN HYPERLIPIDAEMIEN MIT CLOFIBRAT. = TRAITEMENT AU LONG COURS DES DIFFERENTES HYPERLIPIDEMIES PAR LE CLOFIBRATESTUDLAR M; PICHLER O; KINDLER K et al.1975; WIEN. MED. WSCHR.; OESTERR.; DA. 1975; VOL. 125; NO 50-52; PP. 746-751; BIBL. 23 REF.Article

TYPE IV HYPERLIPOPROTEINEMIA. CLOFIBRATE WITHOUT DIETARY THERAPYZELIS R; AMSTERDAM EA; SPANN JF JR et al.1972; J. AMER. MED. ASS.; U.S.A.; DA. 1972; VOL. 222; NO 3; PP. 326-328; BIBL. 12 REF.Serial Issue

Effect of Clofibrate in Jaundiced Full-Term Infants : A Randomized Clinical TrialZAHEDPASHA, Yadollah; AHMADPOUR-KACHO, Mousa; HAJIAHMADI, Mahmood et al.Archives of Iranian medicine. 2007, Vol 10, Num 3, pp 349-353, 5 p.Article

EFFECTS OF CLOFIBRATE ON SOME MICROSOMAL HYDROXYLATIONS INVOLVED IN THE FORMATION AND METABOLISM OF BILE ACIDS IN RAT LIVERANGELIN B; BJORKHEM I; EINARSSON K et al.1976; BIOCHEM. J.; G.B.; DA. 1976; VOL. 156; NO 2; PP. 445-448; BIBL. 31 REF.Article

CLASSIFICATION ET THERAPEUTIQUE DES HYPERLIPIDEMIES: LES TRAITEMENTS NORMOLIPEMIANTS EN 19721972; ENTRET. DE BICHAT, THERAPEUT.; FR.; DA. 1972; PP. 23-26Serial Issue

Clofibrate acutely reverses saline-induced endothelial dysfunction : Role of calcium-activated potassium channelsSANKARALINGAM, Sowndramalingam; DESAI, Kaushik M; WILSON, Thomas W et al.American journal of hypertension. 2006, Vol 19, Num 11, pp 1167-1173, issn 0895-7061, 7 p.Article

Simultaneous determination of clofibrate and its active metabolite clofibric acid in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet absorbance detectionLIHONG DU; YANG XU; MUSSON, Donald G et al.Journal of chromatography. B. 2003, Vol 794, Num 2, pp 343-351, issn 1570-0232, 9 p.Article

The effect of peroxisome proliferators on the metabolism and spectral interaction of endogenous substrates of cytochrome P-450 in rat hepatic microsomesLAKE, B. G; TREDGER, J. M; GRAY, T. J. B et al.Life sciences (1973). 1984, Vol 35, Num 26, pp 2621-2626, issn 0024-3205Article

BINDING TO PLASMA LIPOPROTEINS OF CHLOROPHOXYISOBUTYRIC, TIBRIC AND NICOTINIC ACIDS AND THEIR ESTERS. ITS SIGNIFICANCE FOR THE MECHANISM OF LIPID LOWERING BY CLOFIBRATE AND RELATED DRUGS.BEAUMONT JL; DACHET C.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 25; NO 2-3; PP. 255-266; BIBL. 1 P. 1/2Article

DIE WIRKUNG VON ETOFYLLINCLOFIBRAT AUF DIE ZUSAMMENSETZUNG DER LIPOPCITEINE BEI HYPERLIPOPROTEINAEMEN TYP IIB UND IV = L'ACTION DU CLOFIBRATE D'ETOFYLLINE SUR LA COMPOSITION DES LIPOPROTEINES DANS LES HYPERLIPOPROTEINEMIES DE TYPE IIB ET IVDITSCHUNEIT HH; HUTT V; KLOER HU et al.1980; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1980; VOL. 30; 11B; PP. 2063-2067; ABS. ENG; BIBL. 17 REF.Article

Spectrophotometric determination of clofibrateAGRAWAL, Y. K; PATEL, D. R.Talanta (Oxford). 1987, Vol 34, Num 3, pp 365-366, issn 0039-9140Article